Conference · London, United Kingdom
Molecular Pharming
Biotechnology · Life Sciences
Key numbers
- Editions on record
- 1first in 2012
About Molecular Pharming
Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.
This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.
Meeting Chair: Professor Julian Ma, St Georges Hospital-University London
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 21 Sep 2012 | The Penridge Suite London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Molecular Pharming?
The next dates haven't been confirmed. The last edition we have on record was 21 Sep 2012.
Where is it held?
The last edition we have was at The Penridge Suite, London, United Kingdom.